Approval · Notice of Compliance 31535 · 2023
ESTROGEL: Notice of Compliance 31535
Issued August 31, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 31535
- Date
- August 31, 2023
- Company
- Organon Canada Inc.Kirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To convert the Product Monograph to 2020 format. Safety updates to the Product Monograph.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ESTROGEL | Not yet assigned | — |
Medicinal ingredients
- ESTRADIOL HEMIHYDRATE 0.06 PER